Second STOP After Pioglitazone Priming in CML Patients
Second STOP After Pioglitazone Priming in CML Patients
Recruiting · NCT02889003 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Second STOP After Pioglitazone Priming in CML Patients | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-07-06 | NCT02889003 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Versailles Hospital | 20 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier De Versailles | Le Chesnay | France | 7 |
| Chu de Nantes | Nantes | France | 72 |
| CHU de Rennes | Rennes | France | 16 |
| Chu Lyon | Lyon | France | 22 |
| Hôpital Bicêtre | Le Kremlin-Bicêtre | France | 2 |
| IUCT | Toulouse | France | 5 |